For all the Non-Believers... HIGHLIGHT from bel
Post# of 148184
HIGHLIGHT from below article:
"Our data suggest that pharmacologic inhibition of the CCR1 and/or CCR5 pathways might suppress immune hyperactivation in critical COVID-19.”
https://www.sciencedirect.com/science/article...4820303439
Here is a peer reviewed journal pre-print which piggy backs off Dr. BP's work. Another positive sign the scientific community backs Leronlimab MOA!
Read More: https://investorshangout.com/post/newpost/605...z6WFfhTmmu